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OBJECTIVE: Atrial fibrillation is a common arrhythmia that increases the risk of stroke by four- to five-fold. We
aimed to establish a profile of patients with atrial fibrillation from a population of patients admitted with
acute ischemic stroke or transient ischemic attack using clinical and echocardiographic findings.
METHODS: We evaluated patients consecutively admitted to a tertiary hospital with acute ischemic stroke or
transient ischemic attack. Subjects were divided into an original set (admissions from May 2009 to October
2010) and a validation set (admissions from November 2010 to April 2013). The study was designed as a cohort,
with clinical and echocardiographic findings compared between patients with and without atrial fibrillation. A
multivariable model was built, and independent predictive factors were used to produce a predictive grading
score for atrial fibrillation (Acute Stroke AF Score-ASAS).
RESULTS: A total of 257 patients were evaluated from May 2009 to October 2010 and included in the original
set. Atrial fibrillation was diagnosed in 17.5% of these patients. Significant predictors of atrial fibrillation in the
multivariate analysis included age, National Institutes of Health Stroke Scores, and the presence of left atrial
enlargement. These predictors were used in the final logistic model. For this model, the area under the receiver








The model developed from the original data set was then applied to the validation data set, showing the
preserved discriminatory ability of the model (c statistic = 0.76).
CONCLUSIONS: Our risk score suggests that the individual risk for atrial fibrillation in patients with acute
ischemic stroke can be assessed using simple data, including age, National Institutes of Health Stroke Scores at
admission, and the presence of left atrial enlargement.
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& INTRODUCTION
Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia, and it increases the risk of stroke by
four- to five-fold (1). AF-related ischemic strokes have a
high risk of recurrence and are associated with significant
disability and mortality (2). In 50% of these patients, the
AF pattern is paroxystic or asymptomatic, and although
associated with the same risk of stroke it may not appear on
standard electrocardiography (ECG) or even on the 24-hour
ambulatory ECG recording (Holter) (3,4). Detecting this
arrhythmia is essential because oral anticoagulation therapy
is marked superior to antiplatelet drugs in reducing stroke
risk (5,6).
Clinical features that predict AF occurrence in adults are
well known, including increasing age, valvular heart
disease, coronary artery disease, previous stroke or transient
ischemic attack, diabetes, and history of hypertension or
congestive heart failure (7,8). In patients with acute ischemic
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stroke, other features are also correlated with cardioembolic
stroke related to AF, such as anterior circulation stroke,
severe neurological deficit, and large infarct size. Still, most
of these features are also associated with ischemic stroke
from other causes, such as large vessel disease (8).
Previous studies have established clinical-radiological
scores that predict AF in stroke patients. For example, the
STAF score is calculated using the age of the patient, the
National Institutes of Health Stroke Score (NIHSS) at
admission, the presence of left atrial (LA) dilatation, and
the absence of symptomatic intra- or extra-cranial stenosis
and clinical-radiological lacunar syndrome (9,10). The STAF
score has a sensitivity of 89% and a specificity of 88% for
detecting AF. This score, however, requires information on
the status of the intra- and extra-cranial vasculature, which
is not always available, especially in services that do not
specialize in stroke care (9,10). Actually, in a series of
Brazilian patients with acute stroke consecutively admitted
to general care hospitals, only 27% of the patients had a
carotid ultrasonography, 3.5% had brain magnetic reso-
nance imaging, and 2.9% had digital angiography (11). The
exclusion of a lacunar syndrome generally also requires the
expertise of a neurologist, as most general care physicians
have little familiarity with stroke syndromes. The use of a
simple score based on inexpensive investigation and clinical
data would be of significant interest for everyday use in
community hospitals and in low- and middle-income
countries.
We therefore aimed to establish a profile of patients with
documented AF in a Brazilian population of patients
consecutively admitted with ischemic stroke or transient
ischemic attack (TIA) using only clinical and echocardio-
graphic findings. The possibility of using simple echocar-
diographic and clinical parameters associated with an
enhanced risk of AF in patients with acute ischemic stroke
or TIA may provide a means for determining the need for
further cardiac monitoring, with, for example, a loop event
recorder, to exclude AF as a source of cerebral embolism in
this population.
& METHODS
We evaluated patients consecutively admitted to a
tertiary hospital within 24 hours of symptom onset with
acute ischemic stroke or TIA from May 2009 to April 2013.
Subjects were divided into an original set (patients admitted
from May 2009 to October 2010) and a validation set
(patients admitted from November 2010 to April 2013).
Patients not evaluated with transthoracic or transesophageal
echocardiograms were excluded from the analyses. Clinical
and echocardiographic characteristics were prospectively
collected for each patient according to a standardized
protocol from an institutional outcomes database, as part
of a quality assurance program for stroke treatment. As part
of our hospital stroke program, all patients admitted with
a diagnosis of ischemic stroke or TIA were identified and
followed daily by a case manager nurse. Data collected
included demographics, the presence of stroke risk factors,
the NIHSS score at admission, and the modified Rankin
scale (mRs) score at discharge. Risk factors were considered
if noted on the patient’s chart or if medications for known
risk factors were used either before hospital admission or at
discharge. In our hospital, all patients admitted with acute
stroke are placed under continuous telemetry for at least
the first 24 hours. The definition of AF included a previous
diagnosis based on patient recall confirmed by the attending
physician or by documentation of the first episode of
paroxystic, persistent, permanent, or long-standing AF
during hospitalization through ECG, Holter monitoring, or
cardiac telemetry.
Transthoracic and/or transesophageal echocardiograms
were carried out by three board-certified cardiologists from
our hospital during admission for acute ischemic stroke
or TIA. A comprehensive transthoracic echocardiographic
examination (iE33, Philips Ultrasound Systems, Andover,
Massachusetts, USA) was performed in all patients, with
measurements obtained within 3 [1-5] days of the ischemic
episode. The LA anteroposterior diameter was obtained
from the bidimensional parasternal long-axis view and
analyzed as a dichotomous variable (,4.0 cm vs. $4.0 cm).
The left ventricular ejection fraction (Teichholz formula)
was calculated from M-mode–guided bidimensional mea-
surements of end-diastolic and end-systolic diameters
according to the American Society of Echocardiography
guidelines (12). In case any regional contractile abnormal-
ities were present, the left ventricular volume and ejection
fraction were either calculated from Simpson’s rule or
estimated visually (12). The left ventricular ejection fraction
was categorized as normal when .50%, mild dysfunction
when 40% to 49%, moderate dysfunction when 30% to 39%,
and severe dysfunction when ,30%. The presence of wall
motion abnormalities and valvular dysfunction was noted.
Mitral valve prolapse was defined as leaflet displacement
greater than 2 mm above the plane of the mitral annulus.
Transesophageal echocardiography was performed using a
multiplane probe (Philips Medical Systems, Andover, MA,
USA) following transthoracic examination. Images of the LA
appendage were obtained from the mid-esophagus with a
continuous sweep from 0˚ to 180˚ at 10 –˚15˚ increments. LA
thrombus was considered to be present if there was a well-
circumscribed intra-cavitary echo-dense mass with acoustic
characteristics distinct from the surrounding endocardium/
pectinate muscles detected in more than one imaging plane.
Spontaneous echocardiographic contrast was defined as a
pattern of slowly swirling intracavitary echodensities
imaged with gain settings adjusted to distinguish back-
ground noise and continuously present at standard gain. A
patent foramen ovale was diagnosed if color flow was
observed crossing the fossa ovalis region or if microbubbles
were observed in the left heart up to three heartbeats after
the injection of agitated saline. We considered atrial septal
aneurysm to be present when the total excursion of the atrial
septum within the left and/or right atrium was 11 mm or
larger. The study was designed as a cohort, with clinical
and echocardiographic findings analyzed and compared
between patients with acute ischemic stroke or TIA with
and without AF. The hospital’s Institutional Review Board
approved this study.
Statistical analysis
Means and standard deviations or medians and inter-
quartile intervals were used to describe the patients’
characteristics. The independent samples t test was used
to compare means between patients with and without AF.
Nonparametric data were compared using the Mann-
Whitney test. Categorical variables were compared with the
x2 test. Variables that had an association with AF with a
p-value #0.1 were selected for multivariable analysis. A
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multivariable model was built using the likelihood ratio test
for comparison between nested models. Independent pre-
dictive factors were then used to produce a predictive
grading score for AF, derived by logistic regression analysis
(Acute Stroke AF Score-ASAS). To check the sensitivity
against the false-positive rate of the score, evaluation of
discrimination was performed using the receiver operating
characteristic (ROC) curve. Goodness-of-fit was assessed
with the Hosmer-Lemeshow test. The internal validity of
the prediction model was evaluated by bootstrapping. One
thousand samples of equal size were drawn at random and
with replacement from the complete dataset. In these
bootstrap samples, coefficients of the final regression model
were estimated and tested in the original sample (13). The
amount of ‘‘optimism’’ was measured by calculating the
difference between the area under the ROC curve in the
original sample and bootstrap samples.
Validation of score reproducibility
The reproducibility of the discriminatory power of the
ASAS was assessed by comparing the results of the score
performance in the original set with its performance in the
validation set. The areas under the curve (the c statistic)
were presented for comparison among the prediction model
in the original and validation datasets. Statistical analysis
was performed with SPSS 20.0 software (Chicago, Ill., USA),
and bootstrapping was performed in R version 2.15.1 for
Mac OS X.
& RESULTS
A total of 321 patients with acute ischemic stroke (226) or
TIA (95) were evaluated from May 2009 to October 2010.
Transthoracic (168 patients) or both transthoracic and
transesophageal echocardiograms (89 patients) were per-
formed in 257 patients. AF was diagnosed in 17.5% of the
patients. This group was significantly older, had higher
NIHSS scores at presentation, and was less frequently
independent (modified Rankin scores #2) at discharge.
Before the stroke or TIA admission index, the median
CHADS2 score was 2 (1,4), and the median CHADSVAsc
score was 5 (4,7). AF was more common in patients with
ischemic stroke than in patients with TIA. Five patients had
a previous history of AF and were on anticoagulants at the
time of hospital admission (Table 1).
There were no differences in the frequency of evaluation
with transesophageal echocardiogram in patients with and
without AF (Table 2). LA enlargement was more frequent
in patients with AF than without (28.9% vs. 11.3%, p,0.01,
respectively). Similarly, the presence of spontaneous LA
contrast, mitral valve prolapse, and mitral regurgitation or
stenosis was also significantly more frequent in patients
diagnosed with AF (Table 2). Patients with AF showed a
trend of increased wall motion abnormalities compared
with those without AF (11.1% vs. 5.9%, p = 0.13, respec-
tively), whereas patients without AF had a trend to more
patent foramen ovale than those with AF (6.6% vs. 0%,
p= 0.06, respectively). There were no differences in left
ventricular function, the presence of atrial septal aneurysm,
or the presence of intramural thrombi between the two
groups (Table 2). Significant predictors of AF in the
multivariate analysis included the following (Table 3): age
(adjusted OR: 1.04 95% CI 1.02-1.08), NIHSS (adjusted OR:
1.10 95% CI 1.05-1.16), and the presence of LA enlargement
(adjusted OR: 2.5 95% CI 1.01-6.29). All of these predictors
were used in the final logistic model.
The Hosmer-Lemeshow test revealed a goodness-of-fit
of 10.82, suggesting that the model was well calibrated
(p= 0.21). The area under the ROC curve (AUC) for this
model was 0.79 (95% confidence interval [95% CI 0.71-0.86]),
indicating that the discrimination of the model was high
(Figure 1). The mean area under the 1000 boot- strapped
ROC was 0.79 (95% CI 0.72-0.87). The prediction rule was
then simplified using integer scores based on the regression
coefficients obtained from the logistic regression model. The
score derived from the logistic regression analysis is shown









The relationship between the total ASAS score and AF
was:
Table 1 - Demographics, clinical presentation, and risk factors between patients with and without atrial fibrillation.
Atrial Fibrillation (n= 45) No Atrial Fibrillation (n= 212) p-value
Mean age ¡ SD (years) 80.4¡14.3 69.9¡9.6 ,0.01
Male 51.1% 62.7% 0.14
TIA 15.6% 33.4% 0.02
NIHSS [median, IQ 25, 75] 11 (2-17) 2 [0-6] ,0.01
Hypertension 56.9% 59.6% 0.70
Diabetes 34.8% 31.4% 0.80
Dyslipidemia 23.5% 30.4% 0.40
CAD 7.8% 11.5% 0.60
Smoking (current or previous) 8.9% 15.6% 0.55
Previous Stroke 37.8% 24.1% 0.13
Heart failure 6.7% 1.4% 0.09
CHADS2 Score [median, IQ 25, 75] 2 (1,4) -
CHA2DS2-VASc 5 (4,7) -
Anticoagulation prior to the stroke * 11.1% 0.9% ,0.01
mRs #2 at discharge 60.8% 81% ,0.01
NIHSS: National Institutes of Health stroke scale; mRs: modified Rankin score; CAD: coronary artery disease. *Two patients without atrial fibrillation were
on anticoagulants at admission due to a history of deep venous thrombosis. P-values lower than 0.05 were considered statistically significant.
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where Pr is the probability of AF in patients admitted with
acute ischemic stroke or TIA. A Pr values $0.09 targets AF
with a sensitivity of 82% and specificity of 52% in the
secondary prevention of stroke. The AUC for the predicted
probabilities of the ASAS was 0.78 [95% CI 0.70-0.86],
excluding patients with a previous diagnosis of atrial
fibrillation.
A total of 486 patients were admitted with acute ischemic
stroke (339) or TIA (147) and evaluated with transthoracic
and/or transesophageal echocardiograms from November
2010 to April 2013 (validation set). The model developed
with the original data set was subsequently applied to the
validation data set, showing the preserved discriminatory
ability of the model (c statistic = 0.76, 95% CI 0.69-0.83)
(Figure 1B).
& DISCUSSION
In this study, we developed and validated a clinical
and echocardiographic risk score for patients with acute
ischemic stroke or TIA to identify individuals at risk for AF.
This model may help emergency physicians and neurolo-
gists to detect patients with acute ischemic stroke or TIA at
high risk for AF in daily clinical practice, even in the
absence of vascular neuroimaging.
Although some previous studies have investigated the
predictive value of echocardiographic parameters as possi-
ble risk factors for the occurrence of AF in adults, there is
still no consensus on the best echocardiographic predictors
of AF risk, particularly in patients with acute ischemic
stroke (14,15). Two previous studies evaluated the ability of
scores to help identify patients at risk for AF among patients
with ischemic stroke or TIA (9,16). The STAF score was
calculated from the sum of the points for 4 items: age,
NIHSS, LA enlargement, and the absence of symptomatic
intra- or extra-cranial stenosis or clinico-radiological lacunar
syndrome. This score identified patients with AF with a
sensitivity of 89% and a specificity of 88% (9,10). Although
the sensitivity and specificity of the STAF score are high,
this scoring system requires vascular imaging, which is not
widely available in community hospitals (11). Furthermore,
the value of the STAF score in patients with TIA is uncertain
because such patients were not included in the study. The
LADS score, in contrast, is based on simple criteria,
including the presence of LA enlargement, age, and the
diagnosis of stroke instead of TIA. This score had a
sensitivity of 85.5% and a specificity of 53.1% for the
diagnosis of AF (16). The LADS score, however, is based on
a retrospective, single-center study and was not validated
any further (16). Therefore, the broader applicability of this
score is uncertain.
Our score was based on simple, widely available clinical
and echocardiographic data and showed good calibration
and discrimination. After internal validation, performed by
bootstrapping, the performance of the model remained
high, as evident by the area under the ROC = 0.79 (13).
Furthermore, the ASAS score was developed and internally
validated in a Brazilian population. Brazil has a continental
dimension and a multiethnic population. Genetic studies
have indicated that the Brazilian population has European,
African, and Native Americans constituents (9,17). Therefore,
the use of risk scores developed and validated in the Brazilian
population is of significant importance.
Standard ECG has a poor sensitivity for detecting
paroxysmal AF. Therefore, Holter monitoring is often used
in patients with ischemic stroke, allowing for the detection
of previously unrecognized AF in approximately 2% of
stroke patients (3,4). Recent data suggest that following
acute stroke or TIA, prolonged rhythm recording might
help to identify patients with AF not detected by standard
ECG and Holter (18). Our risk score may help to determine
which patients should undergo more comprehensive
screening with prolonged rhythm monitoring.
There are some limitations to our study. Our relatively
small sample size may have prevented the detection of any
Table 2 - Echocardiographic predictors of atrial fibrillation in patients admitted with acute ischemic stroke or TIA.
Atrial Fibrillation (n= 45) No atrial Fibrillation (n = 212) p-value
Transesophageal echocardiogram performed 28.5% 36.3% 0.48
LVEF* 87.8% 89.7% 0.76
Normal 7.3% 4.9%
Mild dysfunction 4.9% 3.8%
Moderate dysfunction 0.0% 1.6%
Severe dysfunction
Segmental wall motion abnormalities 11.1% 5.9% 0.13
Patent foramen ovale 0% 6.6% 0.06
Atrial septal aneurysm 2.2% 0.9% 0.44
Intramural thrombi 4.4% 1.9% 0.28
Left atrial enlargement 28.9% 11.3 ,0.01
Spontaneous left atrial contrast 4.4% 0% 0.03
Mitral regurgitation or stenosis 11.1% 0.9% ,0.01
Mitral valve prolapse 4.4% 0% 0.03
*LVEF: left ventricle ejection fraction. Normal LVEF.0.50; mild dysfunction = 0.40–0.49; moderate dysfunction = 0.30–0.39; severe dysfunction,0.30.
LVEF = left ventricular ejection fraction.
Table 3 - Results of the multivariable logistic regression
analyses for Atrial Fibrillation.
Variable OR 95% CI p-value
Age ( per year) 1.04 1.02-1.08 ,0.01




NIHSS: National Institutes of Health stroke scale.
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association between other echocardiographic parameters
and the diagnosis of AF. Additionally, we based our
analyses on the use of both transthoracic and transesopha-
geal echocardiography, which have different sensitivities for
the detection of cardiac abnormalities. Only one-third of our
patients had a TEE performed because the investigation of
stroke etiology was performed at the discretion of the
attending physician. However, the frequency of investiga-
tion with TEE was balanced in patients with and without
AF. The LA volume was previously validated in multiple
studies as the gold standard for evaluating prognosis in
several situations, including AF (19). Unfortunately, the LA
volume was not available in more than half of our patients.
However, the LA volume is likely co-linear with the LA
diameter, and the information provided by the LA volume
is partially included in the regression analysis by using the
LA diameter. Finally, because patients did not undergo
further diagnostic monitoring (for example, with a loop
event recorder or a 30-day event monitor), we may have
missed the diagnosis of AF in some patients. Unfortunately,
long-term monitoring is not covered by most health
insurance providers in Brazil and therefore was not
available for the patients included in our series.
Nevertheless, our cohort was the first to specifically
evaluate clinical and echocardiographic predictors of AF
in the context of acute ischemic stroke and TIA in a Brazilian
population and therefore serves as a hypothesis-generating
study.
In conclusion, we developed and validated a risk score for
patients with acute ischemic stroke or TIA to predict the risk
of AF. The final model showed that the individual risk for
AF in patients with acute ischemic stroke or TIA can be
assessed using simple data including age, NIHSS at
admission, and the presence of LA enlargement. The
discriminatory ability of this model and the results of
internal validation showed that the model performed well.
The results of our study suggest that clinical and echocar-
diographic parameters can be used as a tool for screening
patients with acute ischemic stroke to identify those at a
higher risk of AF who should undergo further cardiac
monitoring, to exclude AF as a source of cerebral embolism.
Detection of this arrhythmia is essential because AF-related
strokes have a poor prognosis and high risk of recurrence,
yet anticoagulant treatment dramatically reduces these
risks.
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